Mycobacterium tuberculosis-secreted phosphatases: From pathogenesis to targets for TB drug development

Trends in Microbiology

Volumn 21, Issue 2, 2013, Pages 100-109

  Wong, Dennis ^a   Chao, Joseph D ^a   Av Gay, Yossef ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Mycobacteria; Phosphatase; PtpA; PtpB; SapM; Tuberculosis

Indexed keywords

2 OXO 1,2 DIHYDROBENZO[CD]INDOLE 6 SULFONAMIDE; BENZOFURAN SALICYLATE; BRUNSVICAMIDE DERIVATIVE; CHALCONE DERIVATIVE; DIFLUOROMETHYLPHOSPHONIC ACID; HYDROXYPYRROLE BENZOIC ACID DERIVATIVE; INDOLIN 2 ON 3 SPIROTHIAZOLIDINONE; INDOLIZINE DERIVATIVE; INDOLOQUINOLIZIDINE DERIVATIVE; ISOTHIAZOLIDINONE; ISOXAZOLE AZIDE DERIVATIVE; ISOXAZOLE CARBOXYLATE; ISOXAZOLE SALICYLATE; MACROLINE DERIVATIVE; OXALYLAMINO METHYLENE THIOPHENE SULFONAMIDE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PIPERAZINYL THIOPHENYL ETHYL OXALAMIDE; PRODIGIOSIN DERIVATIVE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE A; PROTEIN TYROSINE PHOSPHATASE B; ROSEOPHILIN DERIVATIVE; SECRETED ACID PHOSPHATASE M; STEVASTELIN DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

BIOGENESIS; COXIELLA BURNETII; DISULFIDE BOND; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FRANCISELLA TULARENSIS; HOST PATHOGEN INTERACTION; HYDROLYSIS; LEGIONELLA PNEUMOPHILA; LISTERIA MONOCYTOGENES; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; PATHOGENESIS; PHAGOSOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA ENTERICA; SEQUENCE HOMOLOGY; SHIGELLA FLEXNERI; SIGNAL TRANSDUCTION; TATLOCKIA MICDADEI; TUBERCULOSIS; YERSINIA;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; ENZYME INHIBITORS; HOST-PATHOGEN INTERACTIONS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PHOSPHORIC MONOESTER HYDROLASES; SIGNAL TRANSDUCTION; TUBERCULOSIS;

CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 84873180453     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2012.09.002     Document Type: Review

References (85)

1. Black D.S., Bliska J.B. Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions. EMBO J. 1997, 16:2730-2744.
2. Persson C., et al. The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. EMBO J. 1997, 16:2307-2318.
3. Heneberg P. Finding the smoking gun: protein tyrosine phosphatases as tools and targets of unicellular microorganisms and viruses. Curr. Med. Chem. 2012, 19:1530-1566.
4. Bach H., et al. Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of human vacuolar protein sorting 33B. Cell Host Microbe 2008, 3:316-322.
5. Wong D., et al. Mycobacterium tuberculosis protein tyrosine phosphatase (PtpA) excludes host vacuolar-H+-ATPase to inhibit phagosome acidification. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:19371-19376.
6. Saleh M.T., Belisle J.T. Secretion of an acid phosphatase (SapM) by Mycobacterium tuberculosis that is similar to eukaryotic acid phosphatases. J. Bacteriol. 2000, 182:6850-6853.
7. Vergne I., et al. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:4033-4038.
8. Beresford N.J., et al. Inhibition of MptpB phosphatase from Mycobacterium tuberculosis impairs mycobacterial survival in macrophages. J. Antimicrob. Chemother. 2009, 63:928-936.
9. Zhou B., et al. Targeting Mycobacterium protein tyrosine phosphatase B for antituberculosis agents. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:4573-4578.
10. Bright N.A., et al. Endocytic delivery to lysosomes mediated by concurrent fusion and kissing events in living cells. Curr. Biol. 2005, 15:360-365.
11. Sturgill-Koszycki S., et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 1994, 263:678-681.
12. Tjelle T.E., et al. Phagosome dynamics and function. Bioessays 2000, 22:255-263.
13. Vergne I., et al. Mycobacterium tuberculosis phagosome maturation arrest: mycobacterial phosphatidylinositol analog phosphatidylinositol mannoside stimulates early endosomal fusion. Mol. Biol. Cell 2004, 15:751-760.
14. Hestvik A.L., et al. Mycobacterial manipulation of the host cell. FEMS Microbiol. Rev. 2005, 29:1041-1050.
15. Av-Gay Y., Everett M. The eukaryotic-like Ser/Thr protein kinases of Mycobacterium tuberculosis. Trends Microbiol. 2000, 8:238-244.
16. Bach H., et al. Mycobacterium tuberculosis PtkA is a novel protein tyrosine kinase whose substrate is PtpA. Biochem. J. 2009, 420:155-160.
17. Koul A., et al. Cloning and characterization of secretory tyrosine phosphatases of Mycobacterium tuberculosis. J. Bacteriol. 2000, 182:5425-5432.
18. Cowley S.C., et al. Expression and localization of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA. Res. Microbiol. 2002, 153:233-241.
19. Chao J.D., et al. Protein kinase and phosphatase signaling in Mycobacterium tuberculosis physiology and pathogenesis. Biochim. Biophys. Acta 2010, 1804:620-627.
20. Chao J.D., et al. Convergence of Ser/Thr and two-component signaling to coordinate expression of the dormancy regulon in Mycobacterium tuberculosis. J. Biol. Chem. 2010, 285:29239-29246.
21. Singh R., et al. Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs. Mol. Microbiol. 2003, 50:751-762.
22. Barr A.J. Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development. Future Med. Chem. 2010, 2:1563-1576.
23. Stehle T., et al. The apo-structure of the low-molecular-weight protein tyrosine phosphatase A (MptpA) from Mycobacterium tuberculosis allows for better target-specific drug development. J. Biol. Chem. 2012, 287:34569-34582.
24. Grundner C., et al. Structural basis for selective inhibition of Mycobacterium tuberculosis protein tyrosine phosphatase PtpB. Structure 2007, 15:499-509.
25. Grundner C., et al. Mycobacterium tuberculosis protein tyrosine phosphatase PtpB structure reveals a diverged fold and a buried active site. Structure 2005, 13:1625-1634.
26. Mascarello A., et al. Inhibition of Mycobacterium tuberculosis tyrosine phosphatase PtpA by synthetic chalcones: kinetics, molecular modeling, toxicity and effect on growth. Bioorg. Med. Chem. 2010, 18:3783-3789.
27. Saleh M.T., Belisle J.T. Secretion of an acid phosphatase (SapM) by Mycobacterium tuberculosis that is similar to eukaryotic acid phosphatases. J. Bacteriol. 2000, 182:6850-6853.
28. Festjens N., et al. Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis. EMBO Mol. Med. 2011, 3:222-234.
29. Saikolappan S., et al. The fbpA/sapM double knock out strain of Mycobacterium tuberculosis is highly attenuated and immunogenic in macrophages. PLoS ONE 2012, 7:e36198.
30. Madhurantakam C., et al. Crystal structure of low-molecular-weight protein tyrosine phosphatase from Mycobacterium tuberculosis at 1.9-A resolution. J. Bacteriol. 2005, 187:2175-2181.
31. Raugei G., et al. Low molecular weight protein tyrosine phosphatases: small, but smart. Cell. Mol. Life Sci. 2002, 59:941-949.
32. Ecco G., et al. Mycobacterium tuberculosis tyrosine phosphatase A (PtpA) activity is modulated by S-nitrosylation. Chem. Commun. (Camb.) 2010, 46:7501-7503.
33. Peterson M.R., Emr S.D. The class C Vps complex functions at multiple stages of the vacuolar transport pathway. Traffic 2001, 2:476-486.
34. Rieder S.E., Emr S.D. A novel RING finger protein complex essential for a late step in protein transport to the yeast vacuole. Mol. Biol. Cell 1997, 8:2307-2327.
35. Clarke M., et al. Retrieval of the vacuolar H-ATPase from phagosomes revealed by live cell imaging. PLoS ONE 2010, 5:e8585.
36. Sun-Wada G., et al. Direct recruitment of H+-ATPase from lysosomes for phagosomal acidification. J. Cell Sci. 2009, 122:2504-2513.
37. Peplowska K., et al. The CORVET tethering complex interacts with the yeast Rab5 homolog Vps21 and is involved in endo-lysosomal biogenesis. Dev. Cell 2007, 12:739-750.
38. Wurmser A.E., et al. New component of the vacuolar class C-Vps complex couples nucleotide exchange on the Ypt7 GTPase to SNARE-dependent docking and fusion. J. Cell Biol. 2000, 151:551-562.
39. Nickerson D.P., et al. Vps-C complexes: gatekeepers of endolysosomal traffic. Curr. Opin. Cell Biol. 2009, 21:543-551.
40. Kinchen J.M., et al. A pathway for phagosome maturation during engulfment of apoptotic cells. Nat. Cell Biol. 2008, 10:556-566.
41. Takeda K., et al. The vacuolar V1/V0-ATPase is involved in the release of the HOPS subunit Vps41 from vacuoles, vacuole fragmentation and fusion. FEBS Lett. 2008, 582:1558-1563.
42. Peters C., et al. Trans-complex formation by proteolipid channels in the terminal phase of membrane fusion. Nature 2001, 409:581-588.
43. Beresford N., et al. MptpB, a virulence factor from Mycobacterium tuberculosis, exhibits triple-specificity phosphatase activity. Biochem. J. 2007, 406:13-18.
44. Saunders B.M., et al. Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect. Immun. 2000, 68:3322-3326.
45. Roach S.K., Schorey J.S. Differential regulation of the mitogen-activated protein kinases by pathogenic and nonpathogenic mycobacteria. Infect. Immun. 2002, 70:3040-3052.
46. Ganguly N., et al. Mycobacterium tuberculosis 6-kDa early secreted antigenic target (ESAT-6) protein downregulates lipopolysaccharide induced c-myc expression by modulating the extracellular signal regulated kinases 1/2. BMC Immunol. 2007, 8:24.
47. Jung S.B., et al. The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes. Infect. Immun. 2006, 74:2686-2696.
48. Grundner C., et al. Protein tyrosine phosphatase PtpA is not required for Mycobacterium tuberculosis growth in mice. FEMS Microbiol. Lett. 2008, 287:181-184.
49. Gupta U.D., Katoch V.M. Animal models of tuberculosis. Tuberculosis (Edinb.) 2005, 85:277-293.
50. Gil O., et al. Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs. PLoS ONE 2010, 5:e10030.
51. Barczak A.K., Hung D.T. Productive steps toward an antimicrobial targeting virulence. Curr. Opin. Microbiol. 2009, 12:490-496.
52. Tan L.P., et al. High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry. Org. Lett. 2009, 11:5102-5105.
53. Combs A.P., et al. Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics. J. Med. Chem. 2005, 48:6544-6548.
54. Chiaradia L.D., et al. Synthetic chalcones as efficient inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase PtpA. Bioorg. Med. Chem. Lett. 2008, 18:6227-6230.
55. Manger M., et al. Discovery of Mycobacterium tuberculosis protein tyrosine phosphatase A (MptpA) inhibitors based on natural products and a fragment-based approach. Chembiochem 2005, 6:1749-1753.
56. Noren-Muller A., et al. Discovery of a new class of inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B by biology-oriented synthesis. Angew. Chem. Int. Ed. Engl. 2008, 47:5973-5977.
57. Soellner M.B., et al. Fragment-based substrate activity screening method for the identification of potent inhibitors of the Mycobacterium tuberculosis phosphatase PtpB. J. Am. Chem. Soc. 2007, 129:9613-9615.
58. Rawls K.A., et al. Design and synthesis of nonpeptidic, small molecule inhibitors for the Mycobacterium tuberculosis protein tyrosine phosphatase PtpB. Org. Biomol. Chem. 2010, 8:4066-4070.
59. Chen L., et al. Identification and characterization of novel inhibitors of mPTPB, an essential virulent phosphatase from Mycobacterium tuberculosis. ACS Med. Chem. Lett. 2010, 1:355-359.
60. Rawls K.A., et al. Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA. Bioorg. Med. Chem. Lett. 2009, 19:6851-6854.
61. Chiaradia L.D., et al. Synthesis, biological evaluation, and molecular modeling of chalcone derivatives as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatases (PtpA and PtpB). J. Med. Chem. 2012, 55:390-402.
62. Noren-Muller A., et al. Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10606-10611.
63. Vintonyak V.V., et al. Identification of thiazolidinones spiro-fused to indolin-2-ones as potent and selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase B. Angew. Chem. Int. Ed. Engl. 2010, 49:5902-5905.
64. Fu Y., Galan J.E. A Salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature 1999, 401:293-297.
65. Humphreys D., et al. The Salmonella effector SptP dephosphorylates host AAA+ ATPase VCP to promote development of its intracellular replicative niche. Cell Host Microbe 2009, 5:225-233.
66. Boyle E.C., et al. Salmonella enterica serovar Typhimurium effectors SopB, SopE, SopE2 and SipA disrupt tight junction structure and function. Cell. Microbiol. 2006, 8:1946-1957.
67. Norris F.A., et al. SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14057-14059.
68. Patel J.C., Galan J.E. Differential activation and function of Rho GTPases during Salmonella-host cell interactions. J. Cell Biol. 2006, 175:453-463.
69. Zhou D., et al. A Salmonella inositol polyphosphatase acts in conjunction with other bacterial effectors to promote host cell actin cytoskeleton rearrangements and bacterial internalization. Mol. Microbiol. 2001, 39:248-259.
70. Kastner R., et al. LipA, a tyrosine and lipid phosphatase involved in the virulence of Listeria monocytogenes. Infect. Immun. 2011, 79:2489-2498.
71. Niebuhr K., et al. Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S. flexneri effector IpgD reorganizes host cell morphology. EMBO J. 2002, 21:5069-5078.
72. Pendaries C., et al. PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection. EMBO J. 2006, 25:1024-1034.
73. Mohapatra N.P., et al. Francisella acid phosphatases inactivate the NADPH oxidase in human phagocytes. J. Immunol. 2010, 184:5141-5150.
74. Aragon V., et al. Legionella pneumophila major acid phosphatase and its role in intracellular infection. Infect. Immun. 2001, 69:177-185.
75. Saha A.K., et al. Properties of an acid phosphatase from Legionella micdadei which blocks superoxide anion production by human neutrophils. Arch. Biochem. Biophys. 1985, 243:150-160.
76. Hill J., Samuel J.E. Coxiella burnetii acid phosphatase inhibits the release of reactive oxygen intermediates in polymorphonuclear leukocytes. Infect. Immun. 2011, 79:414-420.
77. Espinosa A., et al. The Pseudomonas syringae type III-secreted protein HopPtoD2 possesses protein tyrosine phosphatase activity and suppresses programmed cell death in plants. Mol. Microbiol. 2003, 49:377-387.
78. DiGiuseppe Champion P.A., Cox J.S. Protein secretion systems in Mycobacteria. Cell. Microbiol. 2007, 9:1376-1384.
79. Sullivan J.T., et al. The Mycobacterium tuberculosis SecA2 system subverts phagosome maturation to promote growth in macrophages. Infect. Immun. 2012, 80:996-1006.
80. Teitelbaum R., et al. Mycobacterial infection of macrophages results in membrane-permeable phagosomes. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:15190-15195.
81. Clemens D.L., et al. The Mycobacterium tuberculosis phagosome in human macrophages is isolated from the host cell cytoplasm. Infect. Immun. 2002, 70:5800-5807.
82. de Jonge M.I., et al. ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J. Bacteriol. 2007, 189:6028-6034.
83. Muller D., et al. Brunsvicamides A-C: sponge-related cyanobacterial peptides with Mycobacterium tuberculosis protein tyrosine phosphatase inhibitory activity. J. Med. Chem. 2006, 49:4871-4878.
84. Weide T., et al. 3-Substituted indolizine-1-carbonitrile derivatives as phosphatase inhibitors. Bioorg. Med. Chem. Lett. 2006, 16:59-63.
85. Cardona P.J. A dynamic reinfection hypothesis of latent tuberculosis infection. Infection 2009, 37:80-86.